Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma.
Leblanc, Olivia
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma. [electronic resource] - Cancer biology & medicine 02 2020 - 208-217 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2095-3941
10.20892/j.issn.2095-3941.2019.0153 doi
Biomarkers, Tumor--analysis
Cetuximab--pharmacology
Class I Phosphatidylinositol 3-Kinases--genetics
DNA Mutational Analysis
Drug Resistance, Neoplasm--genetics
ErbB Receptors--antagonists & inhibitors
Female
Follow-Up Studies
Gain of Function Mutation
Head and Neck Neoplasms--drug therapy
Humans
Immunohistochemistry
Male
Middle Aged
Progression-Free Survival
Proto-Oncogene Proteins p21(ras)--genetics
Squamous Cell Carcinoma of Head and Neck--drug therapy
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma. [electronic resource] - Cancer biology & medicine 02 2020 - 208-217 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2095-3941
10.20892/j.issn.2095-3941.2019.0153 doi
Biomarkers, Tumor--analysis
Cetuximab--pharmacology
Class I Phosphatidylinositol 3-Kinases--genetics
DNA Mutational Analysis
Drug Resistance, Neoplasm--genetics
ErbB Receptors--antagonists & inhibitors
Female
Follow-Up Studies
Gain of Function Mutation
Head and Neck Neoplasms--drug therapy
Humans
Immunohistochemistry
Male
Middle Aged
Progression-Free Survival
Proto-Oncogene Proteins p21(ras)--genetics
Squamous Cell Carcinoma of Head and Neck--drug therapy